Young person and adult screening KPI data: Q4 summary factsheets
Updated 16 June 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/nhs-screening-programmes-kpi-reports-2020-to-2021/young-person-and-adult-screening-kpi-data-q4-summary-factsheets
Please be aware that this data covers the time period through the COVID-19 pandemic. Provider performance should therefore be interpreted with caution.
In addition to this, some providers were justifiably not able to make timely data returns or validate their data in this period. We recommend looking at the historical trend data of services before the COVID-19 pandemic to help interpret the data.
1. Abdominal aortic aneurysm screening
1.1 KPI AA2: coverage: initial screen
National performance of AA2 in Q1 was withdrawn from publication due to the impact of the COVID-19 pandemic on screening activity. England performance in Q4 was 42.4% as shown in the trend graph below. AA2 is an annual indicator and quarterly figures are cumulative from Q1 to Q4.
Due to the ongoing COVID-19 response and restoration of screening this KPI has been impacted. Performance against the KPI has been affected by when providers restarted primary screening, increased appointment lengths, access to venues and availability of screening staff.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2021 |
|---|---|
| Numerator | 126,754 |
| Denominator | 298,850 |
| Performance | 42.4% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 28.5% |
| Midlands and East | 44.8% |
| North | 33.5% |
| South | 56.2% |
| England | 42.4% |
1.2 KPI AA3: coverage: annual surveillance scan
National performance of AA3 in Q1 was withdrawn from publication as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services in this period. The trend graph below shows that England AA3 performance has dropped below to 81.7%, below the acceptable threshold of 85%.
Due to the ongoing COVID-19 response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2021 |
|---|---|
| Numerator | 2,565 |
| Denominator | 3,138 |
| Performance | 81.7% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 63.6% |
| Midlands and East | 80.0% |
| North | 85.9% |
| South | 83.4% |
| England | 81.7% |
1.3 KPI AA4: coverage: quarterly surveillance scan
National performance of AA4 was withdrawn from publication in Q1 and Q2. Due to impact of the COVID-19 pandemic on screening activity between April and June 2020, there were no quarterly men screened in that period and so their due dates did not move on to Q2. This resulted in a high number of providers reporting very small numbers (less than 5) in Q2 and therefore publication was withdrawn.
The trend graph below shows that England AA4 in Q4 was 88.8%, below the acceptable threshold of 90%.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2021 |
|---|---|
| Numerator | 2,466 |
| Denominator | 2,776 |
| Performance | 88.8% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 80.1% |
| Midlands and East | 85.7% |
| North | 92.3% |
| South | 91.2% |
| England | 88.8% |
2. Diabetic eye screening
2.1 KPI DE1: uptake: routine digital screening
National performance of DE1 in Q4 was 67.7%. The trend graph below shows that DE1 performance has dropped below the acceptable threshold of 75% in last 3 quarters. All 57 screening services submitted data. DE1 is an annual rolling figure.
Due to the ongoing COVID-19 response and restoration of screening this KPI may be impacted and overall numbers will be smaller. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2021 |
|---|---|
| Numerator | 1,011,118 |
| Denominator | 1,492,886 |
| Performance | 67.7% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 70.5% |
| Midlands and East | 61.0% |
| North | 66.7% |
| South | 77.1% |
| England | 67.7% |
2.2 KPI DE2: test: timeliness of results letters
National performance of DE2 in Q4 was 98.4%, lower than the previous quarter. The trend graph below shows that DE2 performance has remained above the achievable threshold of 95% since 1 October 2018. All 57 screening services submitted data.
Due to the ongoing COVID-19 response and restoration of screening this KPI may be impacted and overall numbers will be smaller. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2021 |
|---|---|
| Numerator | 501,277 |
| Denominator | 509,627 |
| Performance | 98.4% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 99.8% |
| Midlands and East | 99.7% |
| North | 95.0% |
| South | 99.7% |
| England | 98.4% |
2.3 KPI DE3: intervention/treatment: timely consultation for people with diabetes who are screen positive
National performance of DE3 in Q4 was 75.7%, the highest it has been in 2 years. The trend graph below shows that DE3 performance has remained below the acceptable threshold of 80% since 1 April 2017. All 57 screening services submitted data.
Due to the ongoing COVID-19 response and restoration of screening this KPI may be impacted and overall numbers will be smaller. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2021 |
|---|---|
| Numerator | 2,034 |
| Denominator | 2,688 |
| Performance | 75.7 |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 78.6% |
| Midlands and East | 78.0% |
| North | 71.3% |
| South | 75.8% |
| England | 75.7% |
3. Bowel cancer screening
3.1 KPI BCS1: uptake
National performance of BCS1 in Q4 was 71.0%, higher than the previous quarter. Publication of BCS1 was withdrawn for Q1. The trend graph below shows that BCS1 performance has remained above the acceptable threshold of 52% since 1 April 2017.
Out of 64 screening services, all of them met the acceptable threshold and 59 met the achievable threshold of 60%.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2021 |
|---|---|
| Numerator | 1,077,043 |
| Denominator | 1,516,288 |
| Performance | 71.0% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| Eastern | 71.8% |
| London | 60.9% |
| Midlands and North West | 69.9% |
| North East | 73.0% |
| Southern | 73.6% |
| England | 71.0% |
3.2 KPI BCS2: coverage
National performance of BCS2 in Q3 was 62.3%, higher than the previous 2 quarters. BCS2 is available 6 months (2 quarters) in arrears. The trend graph below shows BCS2 performance since 1 April 2017. There are no thresholds set for this KPI.
Coverage ranged from 57.2% in London to 65.5% in the South.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2020 |
|---|---|
| Numerator | 5,020,956 |
| Denominator | 8,063,292 |
| Performance | 62.3% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 57.2% |
| Midlands and East | 62.4% |
| North | 61.1% |
| South | 65.5% |
| England | 62.3% |
4. Breast screening
4.1 KPI BS1: uptake
National performance of BS1 up to 31 March 2020 (Q4) is shown in the trend graph below.
Publication of this KPI has been withdrawn for Q1 to Q4 in 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.
4.2 KPI BS2: uptake: screening round length
National performance of BS2 up to 31 March 2020 (Q4) is shown in the trend graph below.
Publication of this KPI has been withdrawn for Q1 to Q4 in 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.
5. Cervical screening
5.1 KPI CS1: coverage under 50 years
National performance of CS1 in Q4 was 68.9%, higher than the previous 2 quarters. The trend graph below shows that CS1 performance has remained below the acceptable threshold of 80% since 1 April 2017.
None of the 135 CCGs met the acceptable threshold.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2021 |
|---|---|
| Numerator | 7,071,719 |
| Denominator | 10,264,947 |
| Performance | 68.9% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 60.7% |
| Midlands and East | 70.6% |
| North | 71.3% |
| South | 71.6% |
| England | 68.9% |
5.2 KPI CS2: coverage 50 years and above
National performance of CS2 in Q4 was 75.0%, the same as the previous quarter and the lowest ever level published for this KPI. The trend graph below shows that CS2 performance has remained below the acceptable threshold of 80% since 1 April 2017.
None of the 135 CCGs met the acceptable threshold.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2021 |
|---|---|
| Numerator | 3,897,682 |
| Denominator | 5,199,083 |
| Performance | 75.0% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 71.6% |
| Midlands and East | 75.8% |
| North | 75.3% |
| South | 75.6% |
| England | 75.0% |